Startup Symposium & InvestConnect Conference Showcases Weill Cornell Medicine Newcos and Spinouts
March 6, 2023
Dr. Behzad Aghazadeh’s professional ambition carried him to different continents, scientific disciplines and career focuses. But the one constant for the Weill Cornell Medicine alumnus has been a commitment to entrepreneurship.
Radiation Oncologist Partners with Enterprise Innovation to Improve Women's Health Technology
February 17, 2023
In recognition of Cervical Health Awareness Month, Enterprise Innovation spoke with radiation oncologist Dr. Onyinye Balogun about her efforts to improve women's health technology. Dr. Balogun shared how an encounter with a cervical cancer patient inspired her to become an entrepreneur.
Neuroscientist Highlights Role of Enterprise Innovation in Advancing Translational Research
February 17, 2023
Enterprise Innovation interviewed rising innovator Dr. Anna Orr. In this conversation, Dr. Orr shares the translational research in neuroscience that is being conducted in her lab as well as how early-career faculty can leverage resources offered by the Weill Cornell Medicine innovation ecosystem to advance their discoveries.
On-Demand Male Contraceptive Shows Promise in Preclinical Study
February 14, 2023
An experimental contraceptive drug candidate developed by Weill Cornell Medicine investigators temporarily stops sperm in their tracks and prevents pregnancies in preclinical models. The study, published in Nature Communications on Feb. 14, demonstrates that an on-demand male contraceptive is possible.
Accelerating BioVenture Innovation Advances Another Cohort of Aspiring Entrepreneurs
December 16, 2022
BioVenture eLab’s intense 15-week Accelerating BioVenture Innovation (ABI) course culminated in an energizing pitch competition on Dec. 6 at Griffis Faculty Club.
$20M Gift to Boost Innovation in Health and Technology
December 8, 2022
By David Nutt
A $20 million gift from Andrew H. ’71 and Ann R. Tisch will foster engagement and collaboration between Cornell Tech and Weill Cornell Medicine, catalyzing new discoveries at the intersection of health and technology – ranging from precision, genomics-based medicine to the use of artificial intelligence and machine learning to improve clinical care.
Understanding Entrepreneurship Adds Value to Scientific Investigators’ Work and Enterprise Innovation Can Help
November 17, 2022
Dr. Nicholas Schiff, the Jerold B. Katz Professor of Neurology and Neuroscience in the Feil Family Brain and Mind Research Institute, was among the early participants in entrepreneurship activity at Weill Cornell Medicine — even before the institution had the complete ecosystem that is Enterprise Innovation today.
Sixth Annual Symposium on Entrepreneurship and Academic Drug Development Highlights Expanding Entrepreneurial Ecosystem
November 17, 2022
When ophthalmologist Dr. John Pena was a first-year resident, he helped to treat a child with a form of cancer that originates in the back of the eye. Dr. Pena used advanced technology to see inside the eye’s clear, gel-like structure called the vitreous, and found abundant microscopic structures that transport biological information from one cell to another.
Weill Cornell Medicine Faculty and Trainees Participate in Conference Featuring Insightful Advice and Stories from Entrepreneurs
October 31, 2022
On Oct. 21, more than 300 Cornell and Weill Cornell Medicine faculty, students and alumni, as well as interested outsiders, joined the 2022 Eclectic Convergence Summit at Cornell Tech on Roosevelt Island. The daylong conference, sponsored by Entrepreneurship at Cornell, included talks from entrepreneurs, business executives and venture capitalists, as well as a pitch competition among business founders from Cornell’s Ithaca campus, Cornell Tech and Weill Cornell Medicine. The day’s talks spanned the gamut of biopharmaceuticals, women’s health, technology and social enterprises.
Center for Technology Licensing at Weill Cornell Addresses Health Inequity and Solutions
October 13, 2022
In celebration of diversity month, Enterprise Innovation’s CTL at Weill Cornell addressed disparities in health and health care affecting underrepresented groups in a special panel on Oct. 11 consisting of experts from academia, industry, government and investment.